This Cough Syrup Ingredient Might Actually Slow Dementia
Scientists at St. Joseph's Health Care London conducted the year-long small study, which involved 55 patients with Parkinson's-related dementia. The drug was safely tolerated and may have stabilized people's symptoms, particularly people more genetically vulnerable to the neurodegenerative disease. Researchers elsewhere have already begun to test ambroxol for Parkinson's and related dementias in larger trials.
'These findings suggest Ambroxol may protect brain function, especially in those genetically at risk. It offers a promising new treatment avenue where few currently exist,' said study author Stephen Pasternak, a cognitive neuroscientist at Lawson Research Institute, the research arm of St. Joseph's Health Care London, in a statement from the university.
The Surprising Connection Between Living Near Golf Courses and Parkinson's Disease
Ambroxol is commonly used as an expectorant in cough syrup, helping thin out mucus so people with respiratory illnesses can clear phlegm from their airways and breathe easier. But recently, scientists have speculated that it can also target a key driver of Parkinson's, the accumulation of abnormal alpha-synuclein in the brain.
Studies have found that ambroxol can raise people's levels of glucocerebrosidase (GCase), another protein that helps regulate the brain's waste clearance system. In people with Parkinson's, levels of GCase tend to decline as levels of abnormal alpha-synuclein rise. It's also known that people with certain genetic mutations affecting GCase function are at higher risk for Parkinson's. Scientists have hoped that ambroxol can indirectly lower people's alpha-synuclein by increasing GCase, reversing or at least slowing down the progression of Parkinson's.
The researchers randomized people with Parkinson's-related dementia to either receive a placebo or a high dose of ambroxol (taken via pills daily) over a 12-month span. There were no severe symptoms linked to the drug's use, the researchers found, and common adverse effects were typically gastrointestinal. People on placebo also experienced worsening psychiatric symptoms of their Parkinson's and an increase in levels of GFAP (a blood marker of brain damage), whereas those on ambroxol appeared to stay about the same.
'This early trial offers hope and provides a strong foundation for larger studies,' Pasternak said.
The team's results, published late last month in JAMA Neurology, were not a clear home run, however. There was overall no difference in cognition between the placebo and treatment groups, for instance. People with GCase-related genetic mutations taking the drug may have experienced improved cognition, though the sample sizes were too small to know for sure.
Scientists Are Testing an Old Cough Medicine as a Parkinson's Disease Treatment
That said, enough evidence has built up that other scientists are taking a chance on ambroxol. There are at least three clinical trials of the drug for Parkinson's and similar conditions linked to GCase underway right now. The largest of these trials is testing ambroxol in over 300 people with Parkinson's over a two-year span. It will take years for these studies to wrap up, but if successful, ambroxol could very well become the first treatment able to slow down the destruction caused by Parkinson's.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Gemma Collins weight-loss drug advert banned
An Instagram post by TV personality Gemma Collins which advertised a weight-loss drug and app has been banned. The star posted: "I'm starting this year two sizes down, thanks to Yazen's weight loss app and medication". It is illegal to advertise prescription-only weight loss drugs and Ms Collins' was one of nine adverts banned in a crackdown by the Advertising Standards Authority (ASA). Ms Collins told the ASA's investigation she accepted her posts had promoted the Yazen weight-loss service and app and she would follow guidance in future. Yazen is a Swedish digital healthcare brand that offers users a doctor-supervised weight-loss programme combining prescription medications with lifestyle coaching. Ms Collins posted a video advert for the brand to her Instagram on 6 January this year. In the now-banned advert, Ms Collins describes how Yazen has helped her and stated: "I'm not telling anyone to go on this medication, but it is prescribed on the NHS." Although the advert didn't name a specific weight-loss medication, the ASA said it made references that breached its code. The ASA said it sought advice from the Medicines and Healthcare products Regulatory Agency, which expressed concern that consumers were likely to be led to request a prescription weight-loss medication. Therefore, the advert was deemed as promoting those medications to the public, breaching ASA rules. The eight other adverts banned for promoting prescription only weight-loss medications to the public were: A paid-for Meta ad for CheqUp Health, which stated "Take the first step to sustainable weight loss with CheqUp". A paid-for Meta ad for which included an image of a partially visible injection pen and code breaching text A paid-for Google search ad for Juniper UK, which stated "GLP-1 Weekly Weight Loss Injection" and featured an image of an injection pen. A paid-for Google search ad for Phlo Clinic, including text that stated, "Get 35% off Weight Loss Order Weight Loss Treatments Online". A paid-for Google ad for SemaPen, which stated "SemaPen Makes Weight Loss Easier." A paid-for Meta ad for Cloud Pharmacy featuring texts messages between two friends discussing new weight-loss medications you can order online. A paid-for Google search ad for which featured text stating "Obesity Treatment Jab" and an image of a box containing a vial of liquid. A paid-for Google search ad for Phlo Clinic, seen on 2 December 2024, which included text that stated "Weight loss Injections". The ASA has ruled that none of these adverts can appear again in their current form. Twix ad banned for encouraging unsafe driving Next ad banned as pose made model look too thin
Yahoo
2 hours ago
- Yahoo
1 dead, over 40 sick as legionnaires' outbreak spreads in southeast London, Ont.
One person is dead and more than 40 people have become ill in an outbreak of legionnaires' disease in London, Ont. The Middlesex-London Health Unit, which declared the outbreak, said the cases were reported within the last week. Most of the people with the severe respiratory illness live and/or work within a six-kilometre radius of one another, in the southeast side of the city, officials said. On Tuesday, officials said the health unit is working closely with Public Health Ontario and the Public Health Ontario Laboratories to investigate and try to determine the source of the outbreak, adding the investigation may take time as they need to do environmental samples of many types of cooling systems. "I know that is what most people are anxious to understand, is where it is coming from, and so are we. Unfortunately, we don't yet have a location," said Dr. Joanne Kearon, the health unit's associate medical officer of health. "Our teams go out to actually collect water samples and swabs from cooling systems and then send that to the lab to compare it to clinical samples from people who have become ill to see if we are able to find the source." The health unit has received 43 reports of Legionella this year, with a few cases reported each month, which Kearon said is expected. However, cases rose to more than 30 last week, prompting officials to declare the outbreak, she added. "Given the weather we've been having, it's understandable that it has spiked," she said. We compare it to what we would expect every season, and this exceeded significantly what we have seen previously." This is the second outbreak of legionnaires' disease in London since last summer. Last year's outbreak was localized in the city's east end and led to two deaths and 30 total reported infections. "At this time, it is not known whether it [the current outbreak] is the same location as the legionnella outbreak from last year," the health unit said. "However, this is being considered as part of the ongoing investigation." Bacteria found in water sources Legionnaires' disease is caused by legionella bacteria, naturally found in water sources such as hot tubs, cooling towers, hot water tanks, large plumbing systems or parts of air-conditioning systems. Legionella is not transmitted from person to person. If the bacteria are aerosolized or misted into the air (via wind or fans), people may inhale the bacteria and become unwell. Most people exposed to legionella don't get ill, but some may experience Pontiac fever, a mild, flu-like illness that commonly resolves itself. Individuals who are older, have lung problems or are immunocompromised (have a weak immune system) are at greater risk of serious infection. While she didn't have specific information about the individuals who contracted the illness, Kearon said there's a wide age range of people who've been affected, and those over 50 are at a higher risk. Health unit officials were not able to determine the exact source of the outbreak last year. The 2024 outbreak came to a natural end by late August as most cooling systems turn off around that time. The health unit predicts that will be the case this year as well. How outbreaks start Legionella bacteria can usually be found in faucets or HVAC units, but ultimately there needs to be an epidemiologic investigation to find the common source, according to Dr. Isaac Bogoch, an infectious disease specialist at Toronto General Hospital. He noted there can be sporadic cases from the soil, but most outbreaks are associated with contaminated water systems and buildings. The disease is not transmitted through human contact. "It's not in the air — it's in water — but you can usually pinpoint it to a common source," he said. "So for example, like an HVAC system in a particular building, you look for where all those people who are infected had a common source of contact." Health officials are able to detect the disease more easily as diagnostics have improved in recent years and more people are aware of it, but Bogoch said that doesn't necessarily mean legionnaires; disease is on the rise. Anyone who develops symptoms such as fever, cough and shortness of breath is encouraged to seek medical attention. All business owners and property managers should ensure all cooling equipment is regularly maintained and sanitized as per the manufacturer's instructions. Although masks can decrease the risk of infection, the health unit is not recommending regular community-wide use of them specifically for the prevention of legionnaire's disease, as the public risk is low.
Yahoo
3 hours ago
- Yahoo
First neighbourhood health services to be rolled out from September
The first neighbourhood health services will be rolled out in England's most deprived areas from September, the Government has said. Council bosses and local health chiefs have been urged to apply to join the first phase of the programme, which will bring tests, post-op care, mental health support and nursing teams closer to people's homes. The initiative is part of the Government's 10-year health plan, which was unveiled by Sir Keir Starmer last week. In his speech, the Prime Minister said the 'status quo of hospital by default will end', with the intention that the majority of outpatient care will happen outside of hospitals by 2035. Local councils and health chiefs have now been urged to apply to the programme by giving examples of innovation in their areas. Applicants will then join a national coaching programme, which will take place over the summer, with 42 sites beginning delivery of services from September. Priority will be given to deprived communities with the greatest need, according to the Department of Health and Social Care (DHSC), with staff focusing on patients with long-term conditions and complex needs. A joint taskforce has been set up by the DHSC and NHS England, chaired by Sir John Oldham, to drive progress. Health Secretary Wes Streeting said: 'Our 10-year health plan committed to building a neighbourhood health service, and we're hitting the ground running on delivering it. 'If we are to get patients cared for faster, on their doorstep and even in their own home, then we need to shift the focus of the NHS from hospitals to the community. 'Today, we are issuing an open invitation to local authorities and health services to become pioneer neighbourhood health services and lead the charge of healthcare reform. 'As part of our plan for change, we're beginning the neighbourhood health service in areas of greatest need first, to tackle the unfair health inequalities that blight our country.' The call comes weeks after Mr Streeting announced that around £2.2 billion previously set aside to plug financial holes will be spent on staff, medicines, new technology and equipment in rural communities, coastal towns and working class regions. The Government is also working on places to create neighbourhood health centres across the country. Eventually, these centres will be open 12 hours a day, six days a week, with teams comprising doctors, nurses, social care workers and pharmacists.
